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Enalapril and low protein reverse chronic puromycm aminonucleoside
nephropathy. The effects of dietary protein and converting enzyme
inhibition (CE!) on chronic puromycin aminonucleoside nephropathy
(PAN) were studied. PAN was induced with seven SQ injections of
puromycin aminonucleoside 20 mg/kg over 10 weeks in male Sprague-
Dawley rats. The rats were divided into a 22.5% protein diet group (Or
1), a 6% protein diet group (Or 2), and an enalapril-treated group on
22.5% protein diet (Gr 3). Group 4 animals served as age-matched
controls. Both diets were isocaloric and had the same phosphorus
content. Rats from groups 1, 2, and 4 were sacrificed at 12, 18 and 24
weeks. Five rats of group 3 were sacrificed at 12 weeks, and the others
were divided in subgroups 3A (diet changed to 6% protein) and 3B (no
changes); half of each subgroup was sacrificed at 18 and 24 weeks,
respectively. Group 2 had significantly less proteinuria than group I at
all times. Group 3 had the same proteinuria as group I until 12 weeks
and then began to decrease. In group 3A proteinuria decreased to group
2 levels, while in group 3B the decrease was slower but still prominent.
Early lesions of focal and segmental glomerular sclerosis/hyalinosis
(FSH) were present in groups 1,2, 3 at 12 weeks (16 1.2%, 15 1.3%,
7 1.3%, respectively, versus 1.3 0.4% in controls), but by 18 weeks
a reversal in FSH was seen in groups 2 and 3A/B (3 1.6%, 2 0.4%,
and 3 0.9%, respectively, vs. 14 1.5% in group 1). This reversal
persisted at 24 weeks (5 2.5%, 3 0.8%, 4 0.8% vs. 18 2.6%).
At 24 weeks mean glomerular diameter was significantly less in group 2
compared to group 1, 100.7 2.0 versus 112.2 2.7,P = 0.009. In
summary, both low protein diet and CE! for 24 weeks reversed both
proteinuria and early FSH lesions in chronic PAN after cessation of PA
injections.
Focal and segmental glomerular scierosis/hyalinosis (FSH)
can be the cause of idiopathic nephrotic syndrome and is the
principal lesion in heroin-induced nephropathy, reflux nephrop-
athy, and the final stages of other glomerulopathies [1].
In the rat FSH develops spontaneously with aging [2], after
renal ablation [3, 4], with induction of diabetes mellitus [5],
after administration of adriamycin [6, 7] and in puromycin
aminonucleoside nephropathy [8—10].
The pathogenesis of FSH in humans and in animal models is
not known. According to one hypothesis, FSH is due to
mesangial cell proliferation and matrix expansion following
various stimuli to mesangial cells [4, 11—13]. An alternative
hypothesis holds that FSH is the consequence of toxic or other
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damage to visceral epithelial cells with subsequent vacuolation,
degeneration and detachment of these cells from the basement
membrane eventually leading to collapse of capillaries accom-
panied by development of "hyaline" insudative lesions in the
glomerular capillary lumina [14, 15]. In this scheme epithelial
lesions are therefore considered as an early stage of segmental
sclerosis.
In a previous study [16], we induced chronic puromycin
aminonucleoside nephropathy (PAN) and examined the effects
of angiotensin converting enzyme inhibition (CEI) on its
course. We found that 12 weeks of CEI had no effect on the
degree of proteinuria or histologic alterations observed in this
model. We now wished to test whether continuing treatment
with a converting enzyme inhibitor after cessation of aminonu-
cleoside injections would result in any improvement in the
course of this model. We also tested the effects of low protein
diet either for the duration of the experiment or after comple-
tion of the injection schedule with or without concomitant CE!.
Methods
Animals
Adult male Sprague-Dawley rats weighing 160 to 200 g at the
beginning of the experiment were used.
Chemicals
Puromycin aminonucleoside (N6, N6-dimethyl-[3-amino-3-
deoxy] adenosine) was purchased from Sigma Chemical Co.
(St. Louis, Missouri, USA). Enalapril ([S]L-[N-(L-ethoxycar-
bonyl-3-phenylpropyl)-l-alanyl]-L-proline) in powder form was
obtained from Merck Sharp and Dohme (West Point, Pennsyl-
vania, USA).
Food
Both kinds of food (22.5% and 6% protein) were purchased
from Tekiad (Madison, Wisconsin, USA). The protein used was
casein and both diets were isocaloric (3.55 Kcal/g). They had
the same amount of fat (5.5%), calcium (0.97%), phosphorus
(0.85%) and magnesium (0.21%). The 22.5% diet had 51.6%
carbohydrates and 6% cellulose and the 6% diet had 73.2%
carbohydrates and 8.2% cellulose.
Biochemistry
Urine protein determinations were performed by the sulfosal-
icylic acid method. Serum creatinine was measured by the Jaffe
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Experimental protocol
1st 3rd 5thI 2nd 4th 6th
.1.
Group 1:
Group 2:
Group 3:
Rats with chronic PAN on a 22.5% protein diet
(N = 24)
Rats with chronic PAN on a 6% protein diet (N = 24)
Rats with chronic PAN on enalapril and 22.5% protein
diet (N = 31)
After 12th week: Group 3A: Diet changed to 6% protein
Group 3B: Continued as before
Group 4: Age-matched controls on a 22.5% protein diet (N = 12)
method. Serum protein was measured by the Lowry method.
Serum cholesterol (fasting) was measured by the enzymatic
method [17] in a Hitachi 737 multichannel chemistry analyzer.
Blood pressure measurements
Systolic blood pressures were measured indirectly with a
tail-cuff sphygmomanometer (NARCO Biosystems, Houston,
Texas, USA) connected to a recorder.
Protocol
The experimental protocol is shown in Figure 1. The rats
were initially divided into four groups (Table 1). Baseline
studies included blood pressure (BP) measurements, 24-hour
urine collection for protein, and serum creatinine and protein
determinations.
Throughout the experiment the urine protein was measured
monthly and before sacrifice. Serum creatinine and protein
were measured every two months and before sacrifice. Serum
cholesterol was measured before the third sacrifice in each
group. BP was determined before each sacrifice.
Group 1 animals (N = 24) received seven subcutaneous
injections of puromycin aminonucleoside (PA; 20 mg/kg diluted
in normal saline, concentration 8 to 9 mg/mI). The first three
injections were given at weekly intervals, and the last four at
biweekly intervals [91. These animals had free access to water
and were given a 22.5% protein diet. Group 2 rats (N 24)
received PA as described above, had free access to water and
were given a 6% protein diet. Group 3 rats (N = 31) received PA
as above and were given a 22.5% diet and enalapril 5 to 10
mg/kg/day [16, 181. These were housed in individual cages and
enalapril was dissolved in drinking water. The solution was
replaced every 48 hours, and its daily consumption was calcu-
lated. Group 4 rats (N = 12)were used as age-matched controls;
they were on 22.5% protein diet.
One-third of the rats of groups 1, 2 and 4 were sacrificed at 12,
18 and 24 weeks. Group 3 had five rats sacrificed at week 12 and
the remaining animals were randomized on the basis of their
proteinuria into two subgroups. Subgroup 3A (N = 13) was
given the 6% diet while continuing on enalapril. Subgroup 3B
(N = 13) was given the 22.5% diet and enalapril. One-half of
each subgroup were sacrificed at 18 and 24 weeks.
At the times of sacrifice, the animals were fasted overnight,
anesthetized with ether, blood samples were drawn, and imme-
diately afterwards the kidneys were removed, weighed and
each of them processed separately.
Tissue processing
One-half of each kidney was fixed in alcoholic Bouin's
solution, embedded in methacrylate, sectioned at 2 pm thick-
ness and stained with periodic acid-Schiff reagent. Three sec-
tions, each 200 m from one another to eliminate assessing the
same glomerulus more than once, were prepared from each
kidney.
Tissue for immunofluorescence was processed by immersion
in isopentane and snap-freezing in liquid nitrogen. Four m
sections were cut. These were stained directly with fluorescein
isothiocyanate (FITC) antibodies raised in goat against rat
albumin, fibrinogen, 1gM, IgG and C3 (Cooper Biomedical,
Inc., Malvern, Pennsylvania, USA). Before use the purity,
specificity and concentration of the FITC antibodies were
checked by Ouchterlony double immunodiffusion [191 and by
immunoelectrophoresis.
A small portion of each kidney was divided into 1 to 2 mm
cubes, fixed in 2.5% glutaraldehyde, post-fixed in 1% osmium
tetroxide, and embedded in Epon. One-micron-thick sections,
stained with toluidine blue, were examined by light microscopy;
thin sections stained with uranyl acetate and lead citrate were
examined with an electron microscope [14].
Morphological assessment
The glomeruli were quantitated for percentage involved with
segmental sclerosis, and the stage or stages of evolution of this
lesion was semiquantitively tabulated. Glomerular morphome-
try was performed using standard methods [201. By moving the
slide from subcapsular to juxtamedullary zones, one hundred
consecutive glomeruli were measured with an eyepiece mi-
crometer. Maximal capillary tuft diameters for each glomueru-
lus were measured. Each kidney was evaluated without the
observer's knowledge of the animal group to which it belonged.
Statistics
The unpaired Student's t-test was used for proteinuria, serum
creatinine, serum protein, and serum cholesterol and BP mea-
surements [21].
The Mann-Whitney U-test for nonparametric values was
used for histologic data [21]. The histological score of each
kidney was considered individually for this calculation. Differ-
PA injections (20 mglkg SQl l2wk l8wk 24wk
7th sacrifice
I
sacrifice
I
sacrifice
I I I I I I I--—I I
0 2 4 6 8 10 12 14
Time, weeks
Table 1. Experimental groups
Fig. 1. Experimental protocol for the
induction of chronic puromycin
-f aminonucleoside nephropathy. Puromycin was
16 18 20 22 24 injected weekly for three weeks and then bi-
weekly for eight more weeks. Animals were
sacrificed at 12 weeks, 18 weeks or 24 weeks.
Marinides et at: Reversal of chronic aminonucleoside nephropathy 751
Table 2. Body weight (grains)
Group 1 Group 2
Group 3
3A 3B Group 4
8 weeks 367 21 256 27 350 19a,b 389 38
12 weeks 375 28 220 16 322 22a,b 407 35
18 weeks 420 53 275 20 352 36' 355 47aI 422 27
24 weeks 421 16 317 5Q 339 2a,b 400 17a,b 473 28
a P < 0.05 group 1 versus group 2, group 3, group 3A, group 3Bb P < 0.05 group 2 versus group 3 or 3A and 3B
Fig. 2. Systolic blood pressure in all five
groups of animals. Only group I at 24 weeks
was hypertensive (131 7 mm Hg). Symbols
are: () group 1; () group 2; (0) group 3;
(U) group 3A; (0) group 3B; (Mill) group 4.
Fig. 3. Serum creatinine in mg/dl. *P < 0.05
for group 1 versus group 2, + P < 0.05 for
group 1 versus group 3B. Symbols are: ()
group 1; () group 2; (0) group 3; (U) group
3A; (0) group 3B; (1111) group 4.
ences were considered significant if the P value was less than
0.05. Results are expressed as mean SEM.
Results
Animals
Group 1 and group 3 animals had slightly decreased growth
compared to the controls (Table 2). However, growth was
profoundly stunted in group 2 compared to all other groups
(Table 2).
Blood pressures
A longitudinal trend towards higher systolic blood pressure
was seen in all groups, most prominently in group 1 (Fig. 2). No
consistent intergroup differences were observed at individual
points of time, and the animals remained normotensive (except
group 1 at 24 weeks, 131 7 mm Hg).
Serum creatinine
There were no consistent patterns in serum creatinines (Fig.
3). Overall, group 1 animals tended to have higher average
values than group 2 or group 3, 1.5 0.2 mg/dl(Gr 1), 1.1 0.2
(Gr 2), 1.3 0.1 (Gr 3A), 0.8 0.1 (Gr 3B) versus 0.8 0.2 of
controls at 24 weeks.
Serum protein
In the early part of the study group 2 animals had lower levels
of total serum protein than those of group 1, but this difference
E
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752 Marinides et al: Reversal of chronic aminonucleoside nephropathy
Hg. 4. Serum protein in g/dl. < 0.05 for
group 1 versus group 2, + P < 0.05 for group
24 1 versus group 3, 3A or 3B. Symbols are: ()group 1; () group 2; (9) group 3; (•) group
3A; (0) group 3B; (Ill) group 4.
Table 3. Proteinuria mg/24 hr
Group I Group 2
Group 3
Group 3A Group 3B Group 4
4 weeks
8 weeks
12 weeks
l5weeks
18 weeks
21 weeks
24 weeks
125 ha
292 33
299 37fl
240 35
278 44
209 29
75 10
151 20
135 15
20 4
17 7
25 8
348±45
60±8
70 51C
32 6"
27 11"
114 17
265 26'
320 26b
309±36
126±28c
90 14
55 14d.e
53 14"
10 2
17 2
16 2
14 3
19 3
24 3
a P < 0.05 between I and 2
b P < 0.05 between 3 and 2
P < 0.05 between 3A and 3Bd P < 0.05 between 1 and 3A/3B
e p< 0.05 between 2 and 3A/3B
disappeared in the second half of the study (Fig. 4). The rats on
enalapril (with or without superimposed low protein diet)
showed a significant decrease of total serum protein in compar-
ison to all other groups at the second half of the experiment.
The rats did not become hypoproteinemic (<6.0 g/dl) at any
point, except group 3B at 18 weeks (5.5 0.3 g/dl). Total
protein was measured rather than albumin since the proteinuria
in this model is non-selective except at the beginning [221.
Fasting serum cholesterol
Serum cholesterol levels at the end of the experiment (week
24) were significantly higher in group 1 (286 20 mg/dl)
compared to group 2 (148 24 mg/dl), group 3A (119 7
mg/dl), groups 3B (107 8 mg/dl) and group 4 (101 2 mg/dl),
P < 0.05. There were no significant differences between groups
2, 3A, 3B and controls.
Proteinuria
All animals in the experimental groups became heavily pro-
teinuric with a progressive increase of proteinuria until the 12th
week (Table 3). Until that time the proteinuria in groups 1 and
3 evolved similarily. Group 2 rats, while significantly protein-
uric compared to controls, were consistently below groups 1
and 3 (P < 0.05), especially at eight weeks and later. After 12
weeks and until the end of the experiment, there was a decrease
in protein excretion in group 2, down to control levels. In
contrast, group 1 rats remained heavily proteinuric throughout
the experiment. Group 3A also showed improvement in pro-
teinuria and by the 21st week these animals were similar to the
controls. Groups 3B had a slower decrease in proteinuria, but
by the 24th week they were not different from controls.
Pathology
On gross examination, kidneys in group 1 were enlarged and
pale with a granular surface. In group 2, the same appearance
was seen at 12 weeks but at 18 and 24 weeks the kidneys were
not as enlarged or granular. Group 3 had similar appearance to
groups I and 2 at 12 weeks. Group 3A kidneys had a gradual
decrease in size and granularity from 18 to 24 weeks, while
group 3B had a lesser degree of improvement.
The weights of the kidneys were averaged and divided by
body weight to account for variations of growth between groups
(Fig. 5). These ratios were significantly higher for groups 1, 2,
and 3 compared to controls at 12 weeks. At the 18th week and
24th week sacrifices, there was a significant decrease of this
ratio to control levels in group 2. There was a similar decrease
in group 3A. In group 3B the ratio remained elevated until 24
weeks.
Measurement of glomerular morphometry at 24 weeks dem-
onstrate that Group 2 had a significantly smaller mean glomer-
ular diameter than Group 1, 100.7 2.0 .s versus 112.2 2.7,
P = 0.009. At 24 weeks Group 4 had a mean glomerular
diameter of 105.3 2.0 ,u which was not different from Group
2 (P = 0.151) and Group 1 (p = 0.093).
The incidence of segmental sclerosis/hyalinosis in each group
and at the various points in time is shown in Table 4. At twelve
10
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Fig. 5. Kidney weight divided by body weight expressed as gI kg.
Symbols are: ()group 1; ()group 2; (0) group 3; (•) group 3A; ()
group 3B; (11111) group 4. P < 0.05 for group 1 versus group 2. + P <
0.05 for group 1 versus 3, 3A or 38.
weeks all three groups had significant sclerosis compared to
controls. But by 18 weeks the incidence of sclerosis had
decreased significantly in all groups except group 1. This
decrease in the incidence of sclerosis persisted at 24 weeks. The
incidence of scierosis/hyalinosis in the individual animals are
shown in Figure 6. Abnormalities of visceral epithelial cells
(vacuolization and reabsorption droplets) were the most fre-
quent findings. Relatively few advanced lesions (hyalinosis)
were seen at this time (Fig. 7C).
At 18 weeks when the animals were no longer subjected to
PA injections, there was a dramatic improvement in histology in
groups 2 and 3AIB. The frequency of the lesions were much less
and when present, they corresponded to the early stage of
evolution of sclerosis (epithelial cell damage). In contrast, the
frequency of lesions not only did not change, but they were
more advanced (a mixture of epithelial damage and hyalinosis
with collapsed capillaries) in group 1.
At 24 weeks, group 1 kidneys showed further progression of
the lesions, whereas the improvement in groups 2 and 3A/3B
persisted with only a few areas of hyalinosis (Fig. 8).
Huge tubular PAS-positive casts and dilated tubules were
seen frequently, and in the most severely affected kidneys
(group 1 at 24 weeks). There was focal tubular atrophy with
interstitial lymphocytic infiltration occasionally disrupting the
tubular basement membrane and extending among the tubular
epithelial cells. There were no hypertensive arteriolar changes
seen.
The ultrastructural findings in all proteinuria groups were
similar. The foot processes of glomerular visceral epithelial
cells were completely or almost completely effaced (Fig. 9A). In
contrast, there was restitution of the normal appearance in
animals in group 2 (Fig. 9B). Other electron microscopic
abnormalities corresponded to those in the light microscopic
preparations in all groups at all stages of the experiments.
There was significant heterogeneity in histology among the
individual animals in each group (Fig. 6). There was good
correlation between the extent of tubulointerstitial lesions and
the degree of proteinuria, gross appearance and weight of the
kidneys, whereas such correlation with the glomerular lesions
was poor.
Immunofluorescence
The pattern of immunofluorescence for albumin, fibrin, com-
plement (C3), and IgG corresponded to the reabsorption drop-
lets of epithelial cells. The immunofluorescence was always
most intense at 12 weeks, with a progressive decrease thereaf-
ter. The immunofluorescence for albumin was always brighter.
There was a trend for more intense immunofluorescence in
group 1 versus group 2. 1gM was localized to the mesangium in
a granular pattern with an intensity of trace to 2+. There was a
progressive increase from 12 weeks to 24 weeks.
Discussion
This study used the chronic form of PAN to examine the
effects of prolonged CE! and low protein diet on the develop-
ment of focal segmental glomerular sclerosis. Chronic PAN is
induced by repeated aminonucleoside injections and is charac-
terized by heavy persistent proteinuria and FSH in 7 to 12% or
more of the glomeruli depending on the particular study and the
duration of follow-up of the disease [8, 9, 16]. It is also possible
to induce a similar chronic form with only one intravenous
injection of PA [231.
The two diets used were isocaloric and had the same content
of phosphorus, calcium and magnesium, in order to exclude any
possible effect of these factors on any beneficial effect from a
low protein diet [24, 25].
The most interesting finding of this study is that whereas low
protein diet and CE! do not affect the course of chronic PAN as
long as the injections of PA continue, they both result in a
marked improvement in both proteinuna and histologic appear-
ance if they are continued after the completion of the PA
injection schedule. A protective effect of dietary protein restric-
tion in chronic aminonucleoside nephrosis using the one injec-
tion model has recently been reported [26]. But in that study
only one time point, 18 weeks, was examined.
By sacrificing animals from the various groups at multiple
points in time, the observation was made that CE! and low
protein diet not only prevented or arrested but actually reversed
the proteinuria and early sclerosis of this model. In the un-
treated group, the damage to the kidneys persisted and pro-
gressed despite the cessation of the aminonucleoside injections.
Comparison of the low protein diet alone, CEI alone and low
protein diet plus CE! demonstrated that the low protein diet
throughout the experiment initially improved and then com-
pletely reversed proteinuria as well as reversing the histologic
lesions of the kidneys to a very significant degree. Treatment
with CE! alone throughout the experiment did not affect pro-
teinuria during the first 12 weeks, whereas it decreased it
significantly during the last 12 weeks, even though this effect
was slower and less prominent than with the low protein diet.
Adding a low protein diet to CE! for the last 12 weeks caused a
more precipitous and complete reversal of proteinuria.
It is true that the degree of sclerosis in the CE! group at 12
weeks was not as high as in the other two experimental groups
(7% vs. 16% and 15%) or as that seen with the same treatment
in our previous study (13%) [161. However, it was still signifi-
cantly higher than in the age-matched controls. It is possible
12 18 24
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Table 4. Incidence of sclerosis
Group I Group 2
Group 3
Group 4Group 3A Group 3B
12 weeks 16 1.2% 15 1.3% 7 1.3%a 1.3 0.4%a(N=6) (N=5) (N=5) (N=3)
18 weeks 13.6 1.5% 3.3 I.6% 2 0.4%at 3 0.9%a 1.5 o.o%
24 weeks
(N=6)
18.1 2.6%
(N=7)
5.4 2.5%a.c
(N=6)3.3 0.8% (N=5)4 8%a.b (N=2)0.6 0.5%
(N=7) (N=8) (N=6) (N=7) (N=4)
a P < 0.05 from group
b P < 0.05 group 3 at 12 weeks versus group 3A and 3B at 18 and 24 weeks
P < 0.05 group 2 at 18 and 24 weeks versus 12 weeks
28 —
24 —
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that this difference is due to sampling error since proteinuria in
the untreated groups and the enalapril-treated groups in both
studies was the same. There was wide scatter in incidence of
sclerosis among the individual animals in most groups (Fig. 6).
It is obvious that the early lesions in the sequence of FSH can
be reversed by appropriate treatment. The exact point beyond
which there is no reversibility is not clear. However, it is
possible that the "hyalinosis" is resolvable because such le-
sions were observed in seven out of nine kidneys in group 2 at
12 weeks, whereas they were not seen in any kidneys at the
18-week sacrifice and in only seven out of 16 kidneys at 24
weeks.
The improvement in glomerular structure was associated
with amelioration of the tubulointerstitial damage and return of
the kidney weight to body weight ratio to normal, suggesting
that renal hypertrophy was reversed. The finding of signifi-
cantly smaller glomerular diameters at 24 weeks in the low
protein diet animals compared to PAN animals also would
suggest reversal of glomerular hypertrophy. Whether this over-
all effect is secondary to the glomerular healing or a concomi-
tant direct effect of either treatment on the tubular lesions is not
clear. The latter possibility is raised because of evidence that
dietary protein content and angiotensin II have regulatory
effects on tubular epithelial growth and regeneration [27, 281.
Differences in systolic blood pressure do not seem important
enough to explain the difference in histology among the various
groups. No arterial or artenolar abnormalities consistent with
systemic hypertension were observed in the kidneys. The
changes in proteinuria and histology are concomitant and it is
unlikely that variations in serum protein levels had a significant
additional effect on the proteinuria. The immunofluorescent
findings were similar in all groups and non-specific, consisting
of protein reabsorption droplets which represented the effects
of the non-selective proteinuria. 1gM was present in the mesan-
gium, most strongly in Group 1 and was probably related to the
development of FSH.
The exact mechanisms through which low protein diet or CEI
cause improvement in FSH cannot be answered by this study.
Single nephron hyperfiltration and/or intraglomerular hyperten-
sion could be considered as the causative mechanisms amena-
ble to correction by either of these treatments [29, 301. How-
ever, the intraglomerular hemodynamics in chronic PAN are
not known with certainty. One study has shown increased
intracapillary hydrostatic pressures nine weeks after induction
of chronic PAN (with a single intravenous PA injection, 50
mg/kg) [31], whereas in another study, repeated measurement
in the same glomeruli over eight weeks showed normal or even
low intraglomerlar capillary pressures [321. In addition, recent
studies doubt the importance of intraglomerular hemodynamics
in the pathogenesis of FSH [33]. An alternative hypothesis is
that FSH is related to the degree of preceding glomerular
hypertrophy regardless of the intracapillary hydrostatic pres-
sures or single nephron glomerular filtration rate [34, 35].
Recently it has been shown that CE! decreases glomerular
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Fig. 6. Incidence of glomeruloscierosis per
animal at the three time points of sacrifice.
Results are expressed as the percentage of
glomeruli involved with sclerosis in the
individual animal. Symbols are: (•) group 1,
(0) group 2, (El) group 3, (A) group 3A, (Lx)
3B, (U) group 4.
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Fig. 7. Light microscopy at 12 weeks showing an early (A), intermedi-
ate (B) and advanced (C) lesion. A shows an early lesion with segmental
enlargement and coarse vacuolization of visceral epithelial cells (ar-
row). Capsular adhesions are also present. B shows an intermediate
lesion with a small group of capillaries obliterated mainly by plasma
protein insudative lesion ("hyalinosis") (arrow). There is also slight
increase in mesangial matrix. C shows an advanced lesion with exten-
sive capillary luminal loss by combined insudative lesions and increased
mesangial matrix-basement membrane material affecting only one of
two glomeruli. (PAS x 200)
surface area (a measure of glomerular hypertrophy) in normal
as well as in partially nephrectomized rats, and that it decreases
mesangial cell proliferation in vitro [36].
Fig. 8. Light microscopy at 24 weeks in group 1 (A), group 2 (B) and
group 4 (C) animals. A is a group I animal showing a glomerulus with
intermediate to advanced segmental sclerosis. B is group 2 animal with
a small segment of sclerosis with "hyalinosis" in this glomerulus. C is
a group 4 (control) animal with glomeruli that are without segmental
sclerosis. (PAS )< 200)
Experiments on growth of tubular epithelial cells in vitro
showed that angiotensin II enhances the mitogenic effects of
epidermal growth factor on these cells (both angiotensin II and
EGF used at "physiologic" concentrations) [281. Finally, it has
been shown that dietary protein intake in the rat is directly
related to plasma renin activity, angiotensin I and aldosterone
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It is possible then that in chronic PAN, low protein diet acts
by decreasing the activity of the renin-angiotensin system in the
kidney, thereby decreasing the hypertrophic/regenerative re-
sponse of the injured podocytes and possibly of the mesangial
cells as well. To the extent that there is indeed a link between
degree of hypertrophy and sclerosis, the profound amelioration
of sclerosis seen in this experiment can also be explained.
The fact that the response to the low protein was more
prominent than to enalapril alone may indicate additional
effects of low protein on above processes, possibly through
changes of renal prostaglandin levels [27, 28], or decrease of
oxidant stress per nephron [37], or through decreased levels of
various growth factors.
The outcome of this study raises the possibility that use of
low protein diet and/or CE! in clinical renal disease with FSH
may allow the reversal of the self-perpetuating process towards
end-stage renal failure and healing of the early FSH lesions.
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